The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 30, 2019
Filed:
Sep. 10, 2014
Applicant:
Alios Biopharma, Inc., South San Francisco, CA (US);
Inventors:
Leonid Beigelman, San Mateo, CA (US);
Robert Than Hendricks, San Carlos, CA (US);
Antitsa Dimitrova Stoycheva, Half Moon Bay, CA (US);
Jerome Deval, Pacifica, CA (US);
Sarah Katherine Stevens, San Francisco, CA (US);
Assignee:
ALIOS BIOPHARMA, INC., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 237/20 (2006.01); C07D 237/24 (2006.01); C07D 403/12 (2006.01); C07D 401/04 (2006.01); C07D 401/08 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 403/08 (2006.01); C07D 403/10 (2006.01); C07D 405/04 (2006.01); C07D 405/06 (2006.01); C07D 405/10 (2006.01); C07D 405/12 (2006.01); C07D 409/10 (2006.01); C07D 409/12 (2006.01); C07D 413/06 (2006.01); C07D 471/04 (2006.01); C07D 498/22 (2006.01); C07D 471/22 (2006.01); C07D 498/10 (2006.01); C07D 519/00 (2006.01); A61K 31/245 (2006.01); A61K 31/50 (2006.01); A61K 31/501 (2006.01); A61K 31/504 (2006.01); A61K 31/506 (2006.01); A61K 31/529 (2006.01); A61K 31/5377 (2006.01); A61K 31/55 (2006.01); A61K 31/553 (2006.01); A61K 45/06 (2006.01); C07D 487/18 (2006.01); C07D 487/22 (2006.01); C07D 498/08 (2006.01); C07D 498/18 (2006.01);
U.S. Cl.
CPC ...
C07D 237/24 (2013.01); A61K 31/245 (2013.01); A61K 31/50 (2013.01); A61K 31/501 (2013.01); A61K 31/504 (2013.01); A61K 31/506 (2013.01); A61K 31/529 (2013.01); A61K 31/5377 (2013.01); A61K 31/55 (2013.01); A61K 31/553 (2013.01); A61K 45/06 (2013.01); C07D 401/04 (2013.01); C07D 401/08 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 403/04 (2013.01); C07D 403/06 (2013.01); C07D 403/08 (2013.01); C07D 403/10 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 405/06 (2013.01); C07D 405/10 (2013.01); C07D 405/12 (2013.01); C07D 409/10 (2013.01); C07D 409/12 (2013.01); C07D 413/06 (2013.01); C07D 471/04 (2013.01); C07D 471/22 (2013.01); C07D 487/18 (2013.01); C07D 487/22 (2013.01); C07D 498/08 (2013.01); C07D 498/10 (2013.01); C07D 498/18 (2013.01); C07D 498/22 (2013.01); C07D 519/00 (2013.01);
Abstract
Disclosed herein are pyridazinone compounds, pharmaceutical compositions that include one or more pyridazinone compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an orthomyxovirus infection, with a pyridazinone compounds. Examples of an orthomyxovirus viral infection includes an influenza infection.